Photo from archive.org
Highlights • As more ICIs are approved, better education is needed for patients and providers.• Major irAEs, signs of worsening immune toxicity, can present with benign symptoms.• IrAEs should be… Click to show full abstract
Highlights • As more ICIs are approved, better education is needed for patients and providers.• Major irAEs, signs of worsening immune toxicity, can present with benign symptoms.• IrAEs should be considered when patients on ICIs present with new symptoms.• Patients on ICIs may present to a variety of healthcare settings with irAEs.• Providers should be educated on basic work-up and treatment options for irAEs.
Keywords:
inhibitor therapy;
therapy induces;
treatment;
combination checkpoint;
induces multiple;
checkpoint inhibitor
Journal Title: Gynecologic Oncology Reports
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Gynecologic Oncology Reports
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!